BioAccord is a compact benchtop LC-MS system that combines the company's BioAccord platform with its Acquity RDA mass detector and MaxPeak high-performance surface technology.

The Waters BioAccord system with Acquity Premier is an easy-to-deploy-and-operate LC-MS system for performing multiattribute monitoring of biotherapeutics. In addition, it gives scientists faster access to mass spectrometry data. Image courtesy of Waters.

The system is designed to improve analyte recovery and assay-to-assay reproducibility, according to Waters. It eliminates analyte-to-metal surface interactions, which in turn can significantly enhance the recovery of hard-to-detect samples, the firm said.

Shipments are expected to begin in late September.

Waters reports Q2 earnings, cites commercial momentum
Lab equipment supplier Waters reported that its second-quarter sales rose by 31% to $682 million, up from $520 million in 2020.

Waters expands collaboration with BTI of Singapore
Waters has expanded its existing collaboration with the Bioprocessing Technology Institute (BTI), a research entity in Singapore's Agency for Science,...

Waters launches Arc Premier liquid chromatography
Lab equipment supplier Waters has unveiled the Arc Premier system, a liquid chromatography system aimed at increasing precision and certainty in chromatography...

Waters debuts mass spectrometer with MRT technology
Waters has introduced its next-generation Select Series multireflecting time-of-flight (MRT) mass spectrometer. The new system is designed to provide...

Waters launches SARS-CoV-2 LC-MS research kit
Lab equipment supplier Waters has debuted a new SARS-CoV-2 liquid chromatography–mass spectrometry (LC–MS) Kit for research use only. The kit uses an...